[Comparative study of chuanxiong and dextran 40 in the treatment of acute cerebral infarction].
This paper reports the results of a double-blind trial in 220 patients with acute cerebral infarction evidenced by CT, who were randomly divided into ligusticum chuanxiong group (134 cases) and low molecular weight dextran group (86 cases). A weighted scoring system was adopted to evaluate the neurologic function and living capability. The results showed that the total therapeutic efficacy rate in chuanxiong group and in dextran 40 group were 86.6% and 62.8% respectively. The effect of chuanxiong on the treatment of acute cerebral infarction was superior to low molecular weight dextran and the difference between the two groups was statistically significant (P less than 0.01).
Chen
D R
DR
Department of Neurology, Changhai Hospital, Second Military Medical College.
D000368:Aged; D000369:Aged, 80 and over; D002544:Cerebral Infarction / Q000188:drug therapy*; D003911:Dextrans / Q000627:therapeutic use*; D004311:Double-Blind Method; D004365:Drugs, Chinese Herbal / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged
D003911:Dextrans; D004365:Drugs, Chinese Herbal